Oxytrol for Women Side Effects
Generic name: oxybutynin
Note: This document contains side effect information about oxybutynin. Some of the dosage forms listed on this page may not apply to the brand name Oxytrol for Women.
Some side effects of Oxytrol for Women may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to oxybutynin: oral syrup, oral tablet, oral tablet extended release
Other dosage forms:
Get emergency medical help if you have any of these signs of an allergic reaction while taking oxybutynin (the active ingredient contained in Oxytrol for Women) hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using oxybutynin and call your doctor at once if you have a serious side effect such as:
-
hot, dry skin and extreme thirst;
-
severe stomach pain or constipation;
-
blurred vision, eye pain, or seeing halos around lights;
-
pain or burning when you urinate; or
-
urinating less than usual or not at all.
Less serious side effects of oxybutynin may include:
-
dry mouth;
-
dry eyes, blurred vision;
-
mild constipation;
-
diarrhea;
-
nausea, mild stomach pain or upset;
-
dizziness, drowsiness, weakness;
-
headache;
-
sleep problems; or
-
runny nose.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to oxybutynin: oral syrup, oral tablet, oral tablet extended release, transdermal film extended release, transdermal gel
Nervous system
Very common (10% or more): Dizziness, somnolence
Common (1% to 10%): Headache, confusion, insomnia, nervousness, convulsions, dysgeusia
Frequency not reported: Heat stroke, paralysis, coma, CNS excitation
Gastrointestinal
Reports of moderate to severe dry mouth was significantly lower in the group of people taking oxybutynin (the active ingredient contained in Oxytrol for Women) extended-release form in a study, at the same daily dose, comparing it to oxybutynin immediate-release. The reported incidence of dry mouth with the extended-release formulation is lower with the use of lower daily doses.
Dry mouth has been mentioned as the primary reason given by patients for discontinuation of therapy.
Very common (10% or more): Dry mouth, constipation, nausea
Common (1% to 10%): Dyspepsia, diarrhea, flatulence, vomiting, decreased GI motility, loose stools, aptyalism, eructation, tongue coated, gastroesophageal reflux, abdominal pain, taste perversion
Uncommon (0.1% to 1%): Dysphagia, frequent bowel movements
Frequency not reported: Taste perversion
Cardiovascular
Common (1% to 10%): Palpitations, peripheral edema, tachycardia, vasodilation, hypertension, chest pain
Uncommon (0.1% to 1%): Hot flush
Rare (less than 0.1%): Chest discomfort
Frequency not reported: Hypotension
Postmarketing reports: QT interval prolongation, arrhythmia, flushing
Dermatologic
Very common (10% or more): Pruritis with transdermal system
Common (1% to 10%): Decreased sweating, dry skin, rash, pruritus
Frequency not reported: Application site vesicles, macules, burning, rash, and erythema with transdermal system.
Genitourinary
Very common (10% or more): Impaired urination, urinary tract infections
Common (1% to 10%): Increased post void retention, urinary retention, impotence, urinary hesitancy, dysuria, pollakiuria
Frequency not reported: Dysuria, cystitis, aggravation of symptoms of prostatic hypertrophy
Endocrine
Postmarketing reports: Suppression of lactation
Metabolic
Uncommon (0.1% to 1%): Anorexia, fluid retention, increased blood glucose
Frequency not reported: Dehydration, aggravation of hyperthyroidism symptoms
Ocular
Very common (10% or more): Blurred vision
Common (1% to 10%): Cycloplegia, dry eyes, mydriasis, keratoconjunctivitis sicca, eye irritation
Frequency not reported: Acute angle closure glaucoma, amblyopia, decreased lacrimation
Postmarketing reports: Glaucoma
Respiratory
Common (1% to 10%): Rhinitis, bronchitis, nasal dryness, oropharyngeal pain, cough, dry throat, sinus/nasal congestion, hoarseness, asthma, dry nasal and sinus mucous membranes
Uncommon (0.1% to 1%): Dysphonia
Frequency not reported: Upper respiratory tract infections, sinusitis, bronchitis, pharyngitis, respiratory failure
Musculoskeletal
Common (1% to 10%): Asthenia, back pain, arthralgia, pain in extremity, flank pain
Frequency not reported: Arthritis
Psychiatric
Common (1% to 10%): Depression, nervousness, insomnia, confusional state
Frequency not reported: Cognitive and mental status changes in elderly patients
Postmarketing reports: Hallucinations, psychotic disorder, agitation, memory impairment
Other
Common (1% to 10%): Fatigue, fungal infection
Uncommon (0.1% to 1%): Thirst
Frequency not reported: Accidental injury, flu syndrome, flushing, fever
Postmarketing reports: Falls
Hypersensitivity
Frequency not reported: Angioedema with airway obstruction, urticaria, and face edema and rare anaphylactic reactions
More Oxytrol for Women resources
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


